Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method enabling the use of extracellular ribonucleic acid (RNA) extracted from plasma of serum to detect, monitor or evaluate cancer or premalignant conditions

Method enabling the use of extracellular ribonucleic acid (RNA) extracted from plasma of serum to detect, monitor or evaluate cancer or premalignant conditions

US Patent 7932061 · Granted Apr 26, 2011

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method enabling the use of extracellular ribonucleic acid (RNA) extracted from p2014
Method enabling use of extracellular RNA extracted from plasma or serum to detec2013
Method of detecting tumor-associated DNA in plasma or serum with a premalignant 2013
Comparative analysis of extracellular RNA species2012
Detection of extracellular tumor-associated nucleic acid in blood plasma or seru2011
Methods for detecting and monitoring cancer using extracellular RNA2011
Method enabling use of extracellular RNA extracted from plasma or serum to detec2011
Method enabling use of extracellular RNA extracted from plasma or serum to detec2011
Detection of 5T4 RNA in plasma and serum2011
Detection of extracellular tumor-associated nucleic acid in blood plasma or seru2011
Method of detecting tumor-associated DNA in plasma or serum from humans without 2011
Method for detection of hTR and hTERT telomerase-associated RNA in plasma or ser2011